Jessica Spence, President, Americas of Edgewell Personal Care Co, filed a Form 4 on November 17, 2026, reporting transactions dated November 13 and November 16, 2026, covering a new restricted stock equivalent award, a vesting conversion, and a tax-withholding share disposition.
Key Highlights
- New RSE grant: Spence acquired 22,728 Restricted Stock Equivalents on November 13, 2026, with a conversion price of $0, vesting in equal thirds on November 13, 2027, 2028, and 2029.
- RSE vesting conversion: 8,826 Restricted Stock Equivalents (granted November 14, 2025) vested and converted into Edgewell common stock on November 16, 2026, at $0 price, via transaction code M.
- Tax-withholding disposition: 4,041 shares of common stock were withheld on November 16, 2026, at $28.38 per share as payment of a tax liability on the vesting of performance stock equivalents.
- Resulting common stock ownership: Following both common stock transactions, Spence directly beneficially owned 9,194 shares of common stock.
- Remaining derivative securities: Spence holds 22,728 of the newly granted RSEs and 17,650 of the November 14, 2025 RSEs following the reported transactions.
- Issuer and exchange: The filing identifies the issuer as Edgewell Personal Care Co, trading on NYSE:EPC.
Spence RSE Transactions: Vesting, New Award, and Tax Withholding on November 16, 2026
According to the Form 4 filed by Jessica Spence, President, Americas at Edgewell Personal Care Co (NYSE:EPC), three separate transactions were reported across two dates. On November 13, 2026, Spence acquired 22,728 Restricted Stock Equivalents (RSEs) at a conversion price of $0. The filing states that one-third of these RSEs will vest and convert into shares of Edgewell common stock on each of November 13, 2027, November 13, 2028, and November 13, 2029, provided Spence is employed on those dates, or all or a portion may vest upon death, disability, change in control, or certain termination events.
On November 16, 2026, two transactions involving common stock were reported. First, 8,826 RSEs originally granted on November 14, 2025 vested and converted into shares of EPC common stock, recorded as an acquisition of 8,826 shares at $0 (transaction code M), bringing Spence's direct common stock holdings to 13,235 shares. Second, 4,041 shares were disposed of (transaction code F) at $28.38 per share, which the filing identifies as shares withheld as payment of a tax liability on the vesting of performance stock equivalents. Following this disposition, Spence's direct beneficial ownership of common stock stood at 9,194 shares.
On the derivative securities side, the November 14, 2025 RSE position was reduced from 26,476 to 17,650 following the vesting of 8,826 units on November 16, 2026. The newly awarded November 13, 2026 RSEs remain at 22,728 units directly held. All transactions were reported as direct ownership. The filing was signed by Jessica Spence and dated November 17, 2026.
What Was Disclosed
The filing disclosed a new 22,728-unit RSE grant to Spence on November 13, 2026, the conversion of 8,826 RSEs into common stock on November 16, 2026, and the withholding of 4,041 shares at $28.38 each for tax purposes, leaving her with 9,194 directly held shares of common stock.




Please wait processing your request...